Neurogene Inc.

NASDAQ: NGNE
Share price (1/6/25): $23.12
Market cap (1/6/25): $343 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 161 pages Agreement and Plan of Merger Among: Neoleukin Therapeutics, Inc.; Project North Merger Sub, Inc.; and Neurogene Inc. Dated as of July 17, 2023

from 8-K 5 pages Form of Lock-Up Agreement August 5, 2019

from 8-K 12 pages Form of Stockholder Support Agreement Article 1 Voting Agreement

from 8-K 84 pages Agreement and Plan of Merger Among: Aquinox Pharmaceuticals, Inc., a Delaware Corporation; Apollo Sub, Inc., a Delaware Corporation; and Neoleukin Therapeutics, Inc., a Delaware Corporation Dated as of August 5, 2019